Our findings indicate that METTL3 inhibits radiotherapy sensitivity by upregulating SLC7A11 expression and mitigating ferroptosis, thereby accelerating the malignant progression of NPC. The gene discussed is SLC7A11; the disease is nasopharyngeal carcinoma.